Cargando…

Dosing patterns for continuous renal replacement therapy in the United States

Detalles Bibliográficos
Autores principales:	Venkataraman, R, Kellum, JA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333403/ http://dx.doi.org/10.1186/cc1283

Ejemplares similares

Does biocompatibility of dialysis membranes affect survival in patients with acute renal failure?
por: Venkataraman, R, et al.
Publicado: (2001)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
por: Giles, LJ, et al.
Publicado: (1998)

Effects of customized bicarbonate buffered solutions for continuous renal replacement therapies on polymorphonuclear function and viability
por: Maccariello, E, et al.
Publicado: (2003)

Outcome of patients with acute renal failure treated with intermittent or continuous renal replacement therapy depending on the initial diagnosis: a retrospective analysis
por: Schroeder, TH, et al.
Publicado: (2002)

Is the ecarin clotting time (ECT) a valid monitoring parameter for r-hirudin-based anticoagulation in continuous renal replacement therapy?
por: v Heymann, C, et al.
Publicado: (2000)

Need for renal replacement therapy in ICU is a marker of morbidity
por: Ostermann, ME, et al.
Publicado: (2002)

PW01-036 – Renal replacement therapy in patients with FMF
por: Papazyan, M, et al.
Publicado: (2013)

Trends in post-operative mortality in patients requiring renal replacement therapy following cardiothoracic transplantation
por: Ostermann, M, et al.
Publicado: (2001)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Lactic versus nonlactic metabolic acidosis: outcomes in critically ill patients
por: Gunnerson, KJ, et al.
Publicado: (2003)

Continuous hemodiafiltration with bicarbonate- and lactate-buffered replacement fluids in septic shock
por: Lewejohann, J-C, et al.
Publicado: (1999)

Postoperative acute kidney injury requiring renal replacement therapy in cardiac surgical patients: risk and protective factors
por: Ampatzidou, F, et al.
Publicado: (2015)

Preoperative aspirin continuation versus replacement therapy with low molecular weight heparin before coronary surgery: effects on postoperative bleeding risk
por: Spadaccio, Cristiano, et al.
Publicado: (2015)

The IL-10 -819T polymorphism is associated with increased susceptibility to severe sepsis
por: Wood, KA, et al.
Publicado: (2003)

The effect of different chloride concentrations in intravenous fluids on patient outcomes
por: Hartman, ME, et al.
Publicado: (2003)

The use of continuous epidural anaesthesia in intensive care units in Poland
por: Szukiewicz, A, et al.
Publicado: (1998)

Continuous EEG recording in the intensive care unit: epileptiform activity
por: Young, GB
Publicado: (2003)

1340. The Effect of Continuous Renal Replacement Therapy on Body Temperature in Patients with and without Infection
por: Challener, Douglas W, et al.
Publicado: (2019)

Long-term thyroid hormone replacement therapy
por: Sowiński, Jerzy
Publicado: (2013)

Enzyme replacement therapy (ERT) in pompe disease
por: Fiumara, Agata
Publicado: (2014)

Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States
por: Kan, Hong, et al.
Publicado: (2014)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Lacosamide dosing in patients receiving continuous renal replacement therapy
por: Chaijamorn, Weerachai, et al.
Publicado: (2023)

Simplified method of regional citrate anticoagulation for continuous extra renal epuration
por: Cointault, O, et al.
Publicado: (2002)

Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies
por: Kempke, Anna P., et al.
Publicado: (2016)

Hormone replacement therapy (HRT): indications and side effects
por: Whitehead, MI
Publicado: (2002)

Renal effects of low-dose dopamine in the critically ill
por: Juste, RN, et al.
Publicado: (1997)

Retrospective study of continuous haemofiltration on patients with acute liver failure with renal dysfunction
por: Antoniades, H, et al.
Publicado: (2003)

Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
por: Guech-Ongey, Mercy, et al.
Publicado: (2010)

418. Fosfomycin Dosing Regimens for The Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Receiving Continuous Renal Replacement Therapy: a Monte Carlo Simulation
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2022)

Distinction between induction and maintenance dosing in continuous renal replacement therapy
por: MacLaren, Graeme
Publicado: (2011)

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Li, Lu, et al.
Publicado: (2020)

Hormone replacement therapy (HRT) and its effect on mammographic specificity and sensitivity
por: Litherland, JC
Publicado: (2002)

Continuous Renal Replacement Therapy Dosing in the Severely Underweight: A Case Report
por: Griffin, Benjamin R., et al.
Publicado: (2019)

Audit of therapeutic drug monitoring of dosing of vancomycin on an intensive care unit
por: Mason, P, et al.
Publicado: (2002)

Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients
por: Martin, Adriana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mdfn370krn35l15hmbm4vt13n3